Annual Drug Patent Expirations for OGSIVEO
Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
This drug has sixty-four patent family members in forty-five countries.
The generic ingredient in OGSIVEO is nirogacestat hydrobromide. One supplier is listed for this compound. Additional details are available on the nirogacestat hydrobromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
